Hobit- and Blimp-1-driven CD4+ tissue-resident memory T cells control chronic intestinal inflammation
Hobit- and Blimp-1-driven CD4+ tissue-resident memory T cells control chronic intestinal inflammation
复制标题
DOI:
10.1038/s41590-018-0298-5
复制
发表时间:
2019-01
影响因子:
30.5
通讯作者:
S. Zundler;E. Becker;M. Spocinska;Monique Slawik;Loreto Parga-Vidal;Regina Stark;Maximilian Wiendl;R. Atreya;T. Rath;M. Leppkes;K. Hildner;R. López-Posadas;S. Lukassen;A. Ekici;C. Neufert;I. Atreya;K. V. van Gisbergen;M. Neurath
中科院分区:
文献类型:
--
作者:
S. Zundler;E. Becker;M. Spocinska;Monique Slawik;Loreto Parga-Vidal;Regina Stark;Maximilian Wiendl;R. Atreya;T. Rath;M. Leppkes;K. Hildner;R. López-Posadas;S. Lukassen;A. Ekici;C. Neufert;I. Atreya;K. V. van Gisbergen;M. Neurath
Although tissue-resident memory T cells (TRMcells) have been shown to regulate host protection in infectious disorders, their function in inflammatory bowel disease (IBD) remains to be investigated. Here we characterized TRMcells in human IBD and in experimental models of intestinal inflammation. Pro-inflammatory TRMcells accumulated in the mucosa of patients with IBD, and the presence of CD4+CD69+CD103+TRMcells was predictive of the development of flares. In vivo, functional impairment of TRMcells in mice with double knockout of the TRM-cell-associated transcription factors Hobit and Blimp-1 attenuated disease in several models of colitis, due to impaired cross-talk between the adaptive and innate immune system. Finally, depletion of TRMcells led to a suppression of colitis activity. Together, our data demonstrate a central role for TRMcells in the pathogenesis of chronic intestinal inflammation and suggest that these cells could be targets for future therapeutic approaches in IBD.